Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
Polyzos
Stergios A
SA
Anastasilakis
Athanasios D
AD
Terpos
Evangelos
E
D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D006961:Hyperparathyroidism / Q000139:chemically induced*; D007093:Imidazoles / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D013274:Stomach Neoplasms / Q000150:complications / Q000188:drug therapy*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid